Lowest survival in patients with only TERT promoter mutations and longest survival for patients with both TERT promoter and IDH mutations are most likely indicative of primary glioblastoma and oligodendroglial histologies, respectively, rather than any direct biological effect of the altered genes. Here, IDH2 is linked to glioblastoma.